Table 2A

Continued

Case no.SiteaDepthbStagebLevel 1Level 2Level 3Highest levelcNo. of occult cancer cellsExistence typePrognosisRecurrencedRecurrent site
5ST3IIIN.E.0/40/110NoneAliveNo
6AT3IIIN.E.0/20/210NoneAliveNo
7ST3IIIN.E.0/100/110NoneAliveNo
8AT3IIIN.E.0/00/210NoneAliveNo
9RT3IIIN.E.0/10/210NoneAliveNo
10RT3IIIN.E.0/10/210NoneAliveNo
11RT2IIIN.E.0/00/110NoneAliveNo
12ST3IIIN.E.0/40/210NoneAliveYesLiver
13RT3IIIN.E.0/20/210NoneDeathYesVagina
14RT3IIIN.E.0/10/410NoneDeathYesLung, brain
15RT3IIIN.E.0/20/1110NoneDeathYesBrain
16RT3IIIN.E.0/40/310NoneDeathYesLocal recurrence in pelvis
17ST3IIIN.E.0/10/110NoneDeathYesLung
18ST2IIIN.E.0/20/210NoneDeathYesLung, liver
19RT2IIIN.E.1/50/222ClusterAliveNo
20ST2IIIN.E.1/30/122SingleAliveNo
21ST3IIIN.E.1/70/221SingleAliveNo
22ST3IIIN.E.1/50/2220SingleAliveNo
23RT3IIIN.E.2/60/122SingleAliveNo
24RT4IIIN.E.1/60/121SingleDeathYesLocal recurrence in pelvis
25RT3IIIN.E.1/30/124ClusterDeathYesBrain
26CT3IIIN.E.2/30/322SingleDeatheNo
27ST3IIIN.E.1/31/236Single + clusterAliveNo
28TT3IIIN.E.4/51/336SingleAliveNo
C. Node-positive patients at level 2
1RT2IIIN.E.N.E.0/520NoneAliveNo
2RT3IIIN.E.N.E.0/520NoneAliveNo
3ST3IIIN.E.N.E.0/320NoneDeathNo
4DT3IIIN.E.N.E.0/120NoneDeathYesLiver
5RT3IIIN.E.N.E.0/620NoneDeathYesLocal recurrence in pelvis
6ST3IIIN.E.N.E.0/220NoneDeathYesLung, bowel anastomosis
7RT3IIIN.E.N.E.0/220NoneDeatheNo
8RT2IIIN.E.N.E.1/232SingleAliveNo
9ST3IIIN.E.N.E.1/131SingleAliveNo
10RT3IIIN.E.N.E.1/332SingleAliveNo
11ST3IIIN.E.N.E.1/631SingleAliveNo
12ST3IIIN.E.N.E.1/334ClusterAliveNo
13RT3IIIN.E.N.E.1/131SingleAliveNo
14RT3IIIN.E.N.E.1/232SingleDeathYesLocal recurrence in pelvis, lung
15RT3IIIN.E.N.E.1/132SingleDeathYesLung
  • a C, cecum; A, ascending colon; T, transverse colon; D, descending colon; S, sigmoid colon; R, rectum; N.E., not examined.

  • b Grade/stage per UICC, International Union Against Cancer.

  • c The farthest level of micrometastasis.

  • d Recurrence within 5 years after surgery.

  • e Death from other diseases.